Answers are grounded in this paper and cite their sources.
Introduction. Prostate biopsy remains a key step in the morphological verification of prostate cancer (PC) before treatment selection; however, it is an invasive procedure and may be associated with infectious complications, hematuria, and acute urinary retention. Advances in multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography / computed tomography have improved the accuracy of non-invasive assessment of the likelihood of clinically significant prostate cancer and have led to discussion on the feasibility of radical prostatectomy without prior morphological verification in carefully selected patients. Potential advantages of this approach include omission of biopsy and biopsy-related complications, shortening the diagnostic pathway, and reduction of the time to radical treatment; however, the risk of surgical overtreatment due to false-positive imaging findings remains. Objective. To analyze published data on the feasibility of radical prostatectomy without prior prostate biopsy in carefully selected patients with high likelihood of clinically significant prostate cancer. Materials and methods. Publications indexed in PubMed, Scopus, Web of Science and eLIBRARY, as well as articles identified on scientific publishing platforms and through reference lists, were analyzed for the period from 2010 to 2026. Fourteen publications relevant to the topic were included in the review: 5 prospective cohort studies, 5 retrospective cohort studies, 3 literature reviews, and 1 case report. No systematic reviews or metaanalyses directly addressing radical prostatectomy without prior prostate biopsy were identified. Results. In most studies, radical prostatectomy without prior morphological verification was performed in patients with a high likelihood of clinically significant prostate cancer based on a combination of clinical, laboratory, and imaging findings. The most used selection criteria included elevated prostate-specific antigen levels, abnormal digital rectal examination findings, PI-RADS 4–5 lesions on multiparametric magnetic resonance imaging, and high likelihood of malignancy on prostate-specific membrane antigen positron emission tomography / computed tomography. In most published series, final histopathological examination confirmed prostate cancer, with a high proportion of clinically significant tumors. At the same time, cases of clinically insignificant prostate cancer, high-grade prostatic intraepithelial neoplasia, and absence of malignancy in the surgical specimen have been reported, indicating a persistent risk of surgical overtreatment. Comparative data did not demonstrate advantages of omitting prior biopsy in terms of recovery of urinary continence, erectile function, or quality of life. A promising direction is the use of intraoperative morphological verification followed by radical treatment within a single anesthetic procedure. Conclusion. Radical prostatectomy without prior prostate biopsy cannot currently be regarded as a standard approach. Its use may be considered in carefully selected patients with a high likelihood of clinically significant prostate cancer based on comprehensive clinical, laboratory, and imaging assessment. The main limitations are the risk of unjustified radical treatment and the absence of morphological data required for comprehensive preoperative risk stratification. Further prospective studies are needed to develop reproducible patient-selection criteria and to evaluate the diagnostic accuracy, oncological safety, and clinical effectiveness of this strategy.
No takes yet. Share an insight, caveat, or question.
Medvedev et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: